Cell Press

SHERPA: Unknown

People

  1. De Stanchina
    De Stanchina
  2. Lowe
    Lowe
  3. Hadjantonakis
    Hadjantonakis
  4. Levine
    Levine
  5. Rudin
    Rudin
  6. Abdel-Wahab
    Abdel-Wahab
  7. Chaudhuri
    Chaudhuri
  8. Ho
    Ho
  9. Lai
    Lai
  10. Leslie
    Leslie

Groups

  1. GSK Faculty (79)
  2. Sloan Kettering Institute Postdocs (56)
  3. Sloan Kettering Institute Faculty (51)
  4. Department of Medicine (41)
  5. MSK Grad Students (30)
  6. Solid Tumor Oncology Division (28)
  7. Center for Hematologic Malignancies (23)
  8. Center for Molecular Imaging and Biotechnology (22)
  9. Tow Center for Developmental Oncology (TCDO) (22)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (21)
Search Within
  1. "2020"
Formats
  1. Journal Article (86)
  2. Editorial (13)
  3. Review (5)
  4. Meeting Abstract (2)
  5. Miscellaneous (2)
Groups
  1. GSK Faculty (79)
  2. Sloan Kettering Institute Postdocs (56)
  3. Sloan Kettering Institute Faculty (51)
  4. Department of Medicine (41)
  5. MSK Grad Students (30)
  6. Solid Tumor Oncology Division (28)

More Groups

People
  1. Elisa De Stanchina (5)
  2. Matthew Hellmann (5)
  3. Scott Lowe (5)
  4. Anna-Katerina Hadjantonakis (4)
  5. Charles Rudin (4)
  6. Ross Levine (4)

More People

Years
  1. 2020 (108)
Publications
  1. Cancer Cell (22)
  2. Cell (17)
  3. Cell Reports (17)
  4. Molecular Cell (8)
  5. Cell Stem Cell (6)
  6. Cell Host & Microbe (5)

More Publications

Results (108)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A p53-independent DNA damage response suppresses oncogenic proliferation and genome instability
    Journal Article

    Fagan-Solis, K. D.; Simpson, D. A.; Kumar, R. J.; Martelotto, L. G.; Mose, L. E.; Rashid, N. U.; Ho, A. Y.; Powell, S. N.; Wen, Y. H.; Parker, J. S.; more...
    Cell Reports (2020)

    Fulltext@MSK | Save
  • Therapeuticstargeting the gut microbiome: Rigorous pipelines for drug development
    Editorial

    Markey, K. A.; van den Brink, M. R. M.; Peled, J. U.
    Cell Host & Microbe (2020)

    Fulltext@MSK | Save
  • Hyperactivation of TORC1 drives resistance to the pan-HER tyrosine kinase inhibitor neratinib in HER2-mutant cancers
    Journal Article

    Sudhan, D. R.; Guerrero-Zotano, A.; Won, H.; González Ericsson, P.; Servetto, A.; Huerta-Rosario, M.; Ye, D.; Lee, K. M.; Formisano, L.; Guo, Y.; more...
    Cancer Cell (2020)

    Fulltext@MSK | Save
  • Evolving significance of tumor-normal sequencing in cancer care
    Review

    Mandelker, D.; Ceyhan-Birsoy, O.
    Trends in Cancer (2020)

    Fulltext@MSK | Save
  • Oncolytic herpes simplex virus prevents premalignant lesions from progressing to cancer
    Journal Article

    Woo, Y.; Reid, V.; Kelly, K. J.; Carlson, D.; Yu, Z.; Fong, Y.
    Molecular Therapy - Oncolytics (2020)

    Fulltext@MSK | Save
  • Regulatory T cells restrain interleukin-2- and blimp-1-dependent acquisition of cytotoxic function by CD4(+) T cells
    Journal Article

    Śledzińska, A.; Vila de Mucha, M.; Bergerhoff, K.; Hotblack, A.; Demane, D. F.; Ghorani, E.; Akarca, A. U.; Marzolini, M. A. V.; Solomon, I.; Vargas, F. A.; more...
    Immunity (2020)

    Fulltext@MSK | Save
  • SnapShot: Splicing alterations in cancer
    Miscellaneous

    Rahman, M. A.; Krainer, A. R.; Abdel-Wahab, O.
    Cell (2020)

    Fulltext@MSK | Save
  • Vitamin B6 addiction in acute myeloid leukemia
    Journal Article

    Chen, C. C.; Li, B.; Millman, S. E.; Chen, C.; Li, X.; Morris, J. P. 4th; Mayle, A.; Ho, Y. J.; Loizou, E.; Liu, H.; more...
    Cancer Cell (2020)

    Fulltext@MSK | Save

    • Cell Press – authorized name for: